Here, we describe a clinical case involving a 19-year-old male diagnosed with schizophrenia and initiated on risperidone 2 mg/day. The dose was gradually built up to 6 mg/day. Within a week, the patient manifested an extensive exanthematous eruption characterized by collarette-shaped desquamation and intense pruritus. The medication was promptly discontinued, and aripiprazole was introduced, resulting in the complete resolution of the cutaneous manifestations within the subsequent week.
No takes yet. Share an insight, caveat, or question.
Maity et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: